WHO ICTRP trial
Evaluation of dorzolamide/timolol fixed-dose combination therapy for the…
JPRN-UMIN000006829 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000006829 |
|---|---|
| Public title | Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues and beta-blocker |
| Scientific title | Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues and beta-blocker - Effect of dorzolamide hydrochloride/timolol maleate fixed-dose combination on intraocular pressure (trough & peak) |
| Primary sponsor | Hospital, University of the Ryukyus |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Glaucoma |
| Interventions | The subjects take dorzolamide hydrochloride / timolol maleate fixed-dose combination eye drop twice a day for 12weeks.The subjects are scheduled to visit a hospital after 4 and 12 weeks and recieve intraocular pressure(trough & peak)… |
| Registration date | Sep 12, 2011 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: